Reuters logo
BRIEF-Amgen and Allergan receive positive chmp opinion for ABP 215
November 10, 2017 / 12:39 PM / 12 days ago

BRIEF-Amgen and Allergan receive positive chmp opinion for ABP 215

Nov 10 (Reuters) - Allergan Plc

* Amgen and Allergan receive positive CHMP opinion for ABP 215 (biosimilar bevacizumab) for the treatment of certain types of cancer

* Amgen Inc - ‍CHMP positive opinion will now be reviewed by European Commission, which has authority to approve medicines for European Union​ Source text for Eikon: Further company coverage:

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below